Regulation of aldosterone secretion by Cav1.3.

Item

http://www.wikidata.org/entity/Q36926861

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Regulation of aldosterone secretion by Cav1.3.

@en

type

Item

label

Regulation of aldosterone secretion by Cav1.3.

@en

prefLabel

Regulation of aldosterone secretion by Cav1.3.

@en

P1476

Regulation of aldosterone secretion by Cav1.3.

@en

P2093

Carmela Maniero

http://www.w3.org/2001/XMLSchema#string

Elena A B Azizan

http://www.w3.org/2001/XMLSchema#string

Gizem Tanriver

http://www.w3.org/2001/XMLSchema#string

Junhua Zhou

http://www.w3.org/2001/XMLSchema#string

Lalarukh Haris Shaikh

http://www.w3.org/2001/XMLSchema#string

Morris J Brown

http://www.w3.org/2001/XMLSchema#string

Richard B Silverman

http://www.w3.org/2001/XMLSchema#string

Sumedha Garg

http://www.w3.org/2001/XMLSchema#string

Wanfeng Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays.

Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.

Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance.

P2888

srep24697

P304

24697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24697

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Soosung Kang

Ada E D Teo

Catherine B Xie

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301576491

http://www.w3.org/2001/XMLSchema#string

P6179

1012507298

http://www.w3.org/2001/XMLSchema#string

P698

27098837

http://www.w3.org/2001/XMLSchema#string

P932

4876952

http://www.w3.org/2001/XMLSchema#string